Short-Term Debt to Capital: Myomo (MYO)

myomo.com - graphic logo of issuer MYO

Myomo, Inc. (MYO) business development relies on physician recognition of robotic systems and the expansion of insurance coverage. Production is based on a combination of outsourcing electronics with final assembly at its own facilities. The price action on GURU.Markets, where the indicator is 0.28, confirms high margins driven by the exclusivity of myoelectric devices and the competition for government subsidies.

MYO - Myomo Inc. Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 10/31/2026
Signature product of myomo.com

Myomo, Inc. (MYO) is developing a unique ecosystem of myoelectric robotics, creating vital rehabilitation tools for patients with paralysis. The current value of 0.28 reflects the share of short-term liabilities within the capital structure, where an increasing ratio of current loans to equity signals either the mobilization of resources for expansion or a risk of liquidity loss during debt servicing.

Competitor analysis for Myomo, Inc.

Short-Term Debt to Capital BSX|EW - Current Liabilities to Capital|Short-Term Debt to Capital RMD (ResMed Inc.)|PODD - Short-Term Debt to Equity Ratio|Zimmer Biomet Holdings - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient The Cooper Companies, Inc. COO|ALGN: Short-Term Debt to Capital|NuVasive (GMED) - Short-Term Debt to Capital|Short-Term Debt to Equity TransMedics Group Inc|Short-Term Debt to Equity ATEC|Short-Term Debt to Capital AORT|Short-Term Debt to Capital Coefficient Enovis Corp|Integra - Short-Term Debt to Equity Ratio|ESTA (Establishment Labs Inc) - Current Liabilities to Equity|Beta Bionics Inc - Short-Term Debt to Capital|Current Liabilities to Capital iradimed.com|EMBC: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio TNDM|Short-Term Debt to Equity Ratio AXGN|SIBN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Orthofix Medical Inc. (OFIX)|Short-Term Debt to Equity Ratio bioventus.com BVS|Short-Term Debt to Capital KIDS (OrthoPediatrics)|Treace Medical Concepts Inc (TMCI) - Current Liabilities to Capital|Strata Critical Medical Corp - Short-Term Debt to Capital|CARL (Carlsmed Medical) - Short-Term Debt to Capital Ratio|RXST: Short-Term Debt to Capital|CLPT - Short-Term Debt to Capital Coefficient|STXS (Stereotaxis) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Neuronetics Inc. (STIM)|Short-Term Debt to Capital SGHT|Short-Term Debt to Capital orchestrabiomed.com (OBIO)|Short-Term Debt to Equity Anika Therapeutics, Inc. ANIK|inspiremd.com - Short-Term Debt to Equity|ZJYL: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital VANI (Vivani Medical, Inc.)|XTNT: Short-Term Debt to Capital|Current Liabilities to Capital NeuroOne Medical Technologies Corp. (NMTC)|Short-Term Debt to Equity Modular Medical Inc|COCH - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio VVOS (Vivos Therapeutics, Inc.)|Short-Term Debt to Capital enVVeno Medical Corporation (NVNO)|Short-Term Debt to Capital SINT (Sintx Technologies, Inc.)|Short-Term Debt to Capital Coefficient Tenon Medical Inc (TNON)|LFWD - Short-Term Debt to Equity|Current Liabilities to Equity AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Bone Biologics Corp.|AXNX (Axonics Modulation Technologies) - Short-Term Debt to Capital|Current Liabilities to Capital Biolase Inc. BIOL|Short-Term Debt to Equity Dynatronics Corporation (DYNT)|paragon28.com - Short-Term Debt to Capital Ratio|INVO Bioscience - Short-Term Debt to Equity Ratio